Marino Garcia
CIK 1669866 · CEO AND PRESIDENT · last filed 2026-03-17
Marino Garcia is a CEO AND PRESIDENT who has filed 9 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing shows the insider exercised options covering $500.0K of DNTH on Mar 17, 2026. Across all open-market trades the lifetime net is −$10.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.36M
3
9
-$10.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | CEO AND PRESIDENT | 65,292 | $82.07 | $5.36M | -$10.02M | 7 | 2026-03-17 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | EVP and Chief Strategy Officer | — | — | — | $0 | 1 | 2018-01-09 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | EVP and Chief Strategy Officer | — | — | — | $0 | 1 | 2016-06-27 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-17 | DNTH | Exer (M) | +65,292 | $500.0K | EDGAR |
| 2026-03-13 | DNTH | Mixed | — | -$9.19M | EDGAR |
| 2026-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-10-03 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-02-04 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-01-26 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-27 | SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Grant (A) | — | $0 | EDGAR |